California Institute for Regenerative Medicine   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: San Francisco CA United States (2004)

Organization Overview

First Clinical Trial
2012
NCT01458405
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

California Institute for Regenerative Medicine